Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone replacement therapy should be used for men with low testosterone levels and symptoms of hypogonadism, after careful diagnosis and considering individual needs.

Finasteride effectively and safely treats recurrent priapism in children and adolescents with sickle cell disease.

The man's fatigue and erectile dysfunction were improved by treating his obesity-related low testosterone without needing testosterone replacement.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

The patient was diagnosed with anorexia nervosa and severe malnutrition, requiring urgent refeeding and monitoring.

The therapies improved ejaculation disorders and sexual function in middle-aged men.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Finasteride can cause lasting sexual, emotional, and cognitive issues, with varying severity.

New treatments for male hypogonadism are effective and should be personalized.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

The combination of cyproterone acetate and testosterone enanthate is highly effective in preventing sperm production and could be a good reversible male contraceptive.

Finasteride caused long-term sexual and non-sexual side effects in young men with hair loss.

A male with aromatase deficiency improved bone health with estradiol treatment.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Some men taking finasteride for hair loss may experience sexual problems like erectile dysfunction and decreased sex drive, which can persist even after stopping the medication.

Nandrolone might increase muscle mass with fewer side effects than testosterone but could cause erectile dysfunction and needs more research.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Finasteride use can cause lasting negative effects like sexual dysfunction, depression, anxiety, and cognitive issues.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

Finasteride, a drug used for certain conditions, can cause serious side effects like sexual dysfunction, suicidal thoughts, and increased diabetes risk, and there's a need for more awareness and research about these effects.

Hormonal male contraception is effective and could be market-ready, but more research is needed to ensure safety for all ethnic groups.

Testosterone is key for male sexual function, and treating hormone imbalances can improve sexual issues.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Finasteride doesn't affect erections much, but may decrease libido in men.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.